An IPSC Cell-Based Model of Macular Degeneration for Drug Discovery
Wahlin Karl, Ph.D.
California Institute for Regenerative Medicine
Complement Factor H Mutant Pluripotent Stem Cells to Model Early Onset Macular Degeneration and their Application in Drug Discovery
Wahlin Karl, Ph.D.
BrightFocus Foundation
Microenvironment Based Optimization of Retinal Induction Using Crispr-Cas9 Reporter Pluripotent Stem Cells as an Expandable Source of Retinal Progenitors and Photoreceptors
Wahlin Karl, Ph.D.
California Institute for Regenerative Medicine
Modeling Photoreceptor Development and Disease Using Human Pluripotent Stem Cells